Orca Bio Revenue and Competitors
Estimated Revenue & Valuation
- Orca Bio's estimated annual revenue is currently $26.7M per year.
- Orca Bio's estimated revenue per employee is $201,000
- Orca Bio's total funding is $192M.
- Orca Bio's current valuation is $1B.
Employee Data
- Orca Bio has 133 Employees.
- Orca Bio grew their employee count by 15% last year.
Orca Bio's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Co-Founder and CEO | Reveal Email/Phone |
2 | Co-Founder | Reveal Email/Phone |
3 | CEO | Reveal Email/Phone |
4 | Head Talent | Reveal Email/Phone |
5 | VP Market Access | Reveal Email/Phone |
6 | Head Clinical QA | Reveal Email/Phone |
7 | Head Strategy and Analytics | Reveal Email/Phone |
8 | VP, Controller | Reveal Email/Phone |
9 | VP, Manufacturing and CMC Development | Reveal Email/Phone |
10 | SVP, Regulatory Affairs | Reveal Email/Phone |
Orca Bio Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $84.8M | 422 | 24% | N/A | N/A |
#2 | $0.4M | 2 | 0% | N/A | N/A |
#3 | $32M | 159 | 3% | N/A | N/A |
#4 | $35M | 121 | 3% | $62.5M | N/A |
#5 | $30.2M | 150 | 18% | N/A | N/A |
#6 | $135.3M | 673 | 0% | N/A | N/A |
#7 | $110.3M | 549 | N/A | N/A | N/A |
#8 | $60.1M | 299 | -4% | N/A | N/A |
#9 | $554.8M | 1725 | 2% | N/A | N/A |
#10 | $10.5M | 52 | 4% | N/A | N/A |
What Is Orca Bio?
Orca Bio is a clinical-stage biotechnology company developing a pipeline of high precision allogeneic cell therapy products that are designed to safely replace patientsￃﾢ￢ﾂﾬ￢ﾄﾢ diseased blood and immune system with a healthy one. Our manufacturing platform sorts donor blood with single-cell precision and a high level of purity and speed, enabling us to create proprietary, optimal therapeutic mixtures of immune and stem cells that have the potential to transform allogeneic cell therapy. Our talented team is driven by a passion for science and compassion for patients.
keywords:N/A
$192M
Total Funding
133
Number of Employees
$26.7M
Revenue (est)
15%
Employee Growth %
$1B
Valuation
N/A
Accelerator
Orca Bio News
Company aims to safely and effectively regenerate a healthy blood and immune system for patients with hematological malignancies, genetic diseases and autoimmune disorders High precision cell therapies manufactured by Orca Bio have the potential to replace conventional bone marrow transplants a ...
The funding round, which brings the total amount of money Orca has raised to nearly $300 million since it was launched in 2016, will be used to develop its pipeline of cell therapies and its manufacturing technology, which involves optimizing therapeutic mixtures of immune and stem cells by sort ...
Other Companies in Menlo Park
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $23.9M | 133 | 48% | N/A |
#2 | $42.9M | 134 | 0% | $8.6M |
#3 | $15M | 136 | 6% | N/A |
#4 | $19.2M | 137 | -53% | $310.6M |
#5 | $21.5M | 139 | 15% | $189.5M |